This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Westell Tech, Somaxon: Volume Movers

BOSTON ( TheStreet) -- Westell Technologies (WSTL - Get Report) was one of several stocks trading near $5 poised to move on above-average volume Thursday after the company reported fiscal first-quarter results that topped an analyst's view.

Westell Technologies said it had a fiscal first-quarter profit of 7 cents a share, more than doubling the lone analyst target for a profit of 3 cents a share. Revenue of $41.3 million fell from a year ago and was below the single analyst estimate of $47.1 million, although it was up from $37.8 million in the prior quarter. Also on the positive side, gross margin rose to 37.8% from 28.4% in the year-ago period.

Shares of Westell Technologies jumped by 26 cents, or 15.7%, to $1.82 in Wednesday's late trading session. The average daily share volume for Westell is 149,000.

Elsewhere, Somaxon Pharmaceuticals (SOMX) rose by 15 cents, or 4.4%, to $3.59 in Wednesday's after-hours session after the company said that detailed results from two Phase 3 clinical trials of the company's sleep drug Silenor have been accepted for publication in peer-reviewed scientific journals. The average daily share volume for Somaxon is 2.5 million.

Also among Thursday's early winners, Banner (BANR - Get Report) climbed by 6 cents, or 3%, to $2.06 in the premarket session after the bank holding company late Wednesday posted a second-quarter loss of 28 cents a share, which narrowed from a year-ago loss of $1.04 a share. Banner said it recorded a $16 million provision for loan losses in the second quarter, down sharply from $45 million in the year-ago quarter but up slightly from $14 million in the preceding quarter. The average daily share volume for Banner is 3.02 million.

On the downside, Uroplasty (UPI) slumped by 28 cents, or 7.4%, to $3.50 in the premarket session after the medical device company announced a public offering of common stock. The average daily share volume for Uroplasty is 199,000.

Cascade Financial (CASB) fell by 6 cents, or 11.8%, to 45 cents in Wednesday's after-market session after the company posted a second-quarter loss of $2.02 a share, which includes accruals for preferred stock dividends and accretion of the issuance discount on preferred stock issued to the Treasury Department. The average daily share volume for Cascade is 141,000.

Mela Sciences (MELA - Get Report) dropped by 66 cents, or 10.2%, to $5.81 in Wednesday's late trading session after the Food and Drug Administration delayed a panel meeting to review the MelaFind skin cancer screening device from Aug. 26 to November 2010. The average daily share volume for Mela Sciences is 571,000.

-- Written by Robert Holmes in Boston.

Check out all of Thursday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of on Facebook.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
UPI $1.22 -2.40%
BANR $52.51 0.00%
MELA $1.21 0.00%
WSTL $1.44 0.00%
AAPL $117.81 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs